4-5

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

Aurolab, based in southern part of India, is an integral part of the Aravind Eye Care System. It manufactures a wide range of high quality ophthalmic consumables such as intraocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments.

CASSEL RESEARCH LABORATORIES PVT LTD, Established its supremacy with human spirit in 1995. The plant has received WHO GMP and ISO 9001:2000 certification and is in process of obtaining other certification.
As a young and quality assured enterprises Cassel has quietly leveraged on its core competence catering World Class Pharmaceutical formulation with total commitment to quality.

Part of the USD 265 million Aarti Group of Industries, Aarti Drugs Ltd (ADL) was established way back in in 1984.
Since its inception, the Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.

ZANEKA HEALTH CARE PVT LTD. is manufacturing more than 400 formulations in the form of tablets, capsules, Dry syrup (Beta Lactum & Non Beta lactum), Ointments, Liquid Syrup & Dry Powder Injections (Beta Lactum)
They at ZANEKA believe that if their customer is happy then they are happy. They are committed to deliver high standard of product and develop products with the feedbacks from the customer and the final consumer following the proper WHO GMP guidelines.

Piramal Healthcare Ltd, a Piramal Group company, is a globally integrated healthcare company that fulfills unmet medical needs across the world. It has a growth track record of above 29% CAGR since 1988. Piramal Healthcare had consolidated revenues of US$ 656 million in FY2009. PHL is currently ranked 4th in the Indian market with a diverse product portfolio spanning several therapeutic areas.